Clinical Trial Update: Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)

View source ↗

Summary

This clinical trial investigating how growth hormone deficiency and growth hormone replacement affect serum FGF21 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: University of Liverpool | Conditions: Growth Hormone Deficiency | Status: WITHDRAWN